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Abstract
Dengue, one of the most common mosquito‐borne viral infectious diseases in the world, 
is caused by the dengue virus (DENV). This enveloped RNA virus has immunologi‐
cally distinct serotypes that increase the risk of life‐threatening diseases, such as den‐
gue haemorrhagic fever. However, no effective antiviral therapy against DENV infection 
has yet been established. As seen in other RNA viruses, various cellular factors have 
been reported to participate in efficient DENV replication. On the other hand, increas‐
ing recent evidence demonstrates that host cells harbour inhibitory factors that limit the 
DENV replication. In particular, it is well known that the response of interferons (IFNs), 
the first line of a host defence system against invading pathogens, evokes the expression 
of a number of genes that negatively regulate various steps of virus replication. This 
set of inhibitory genes, called interferon‐stimulated genes (ISGs), is considered to be a 
central force in IFN‐mediated antiviral responses. In this chapter, we focus our attention 
on the cellular factors involved in DENV infection, particularly to those that modulate 
DENV replication through their association with viral RNA. In addition, we also sum‐
marize general experimental approaches for identifying the host factors of RNA viruses, 
including DENV.
Keywords: dengue virus, cellular factors, RNA untranslated regions, interferon‐
stimulated genes, identification systems
1. Introduction
Dengue virus (DENV) is an enveloped and positive‐strand RNA virus that belongs to the 
genus Flavivirus of the Flaviviridae family [1]. An important characteristic of the Flavivirus 
is that this genus consists of a large number of arthropod‐borne viruses, many of which 
are transmitted by mosquitoes and ticks. In addition, flavivirus infection often causes 
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life‐threatening diseases in humans, such as haemorrhagic fever, encephalitis, and men‐
ingitis [2]. Recently, the Zika virus (ZIKV), a member of the flavivirus family that has 
spread explosively throughout the Americas, is reported to be associated with neurological 
complications [3, 4]. Flaviviruses, therefore, have significant clinical as well as economic 
impacts on modern society.
DENV is a mosquito‐borne virus widely distributed in the tropical and subtropical areas of 
the world. This flavivirus infection is transmitted to humans via the bite of infected mos‐
quitos. The primary vector of DENV infection is Aedes aegypti, while Aedes albopictus, which 
originated in Asia but has extended its range to other regions of the world, is also capable of 
spreading a dengue outbreak. DENV has four antigenically distinct serotypes (from DENV‐1 
to DENV‐4). Primary infection with one of the serotypes is often asymptomatic or causes self‐
limiting dengue fever (DF). However, secondary infection of different serotypes increases the 
risk of more serious forms of DENV infection, such as dengue haemorrhagic fever (DHF) and 
dengue shock syndrome (DSS), due to the presence of non‐ or sub‐neutralizing antibodies 
generated during the primary infection. Therefore, dengue is a significant threat to humans, 
yet there is currently no specific antiviral available for DENV infection [1, 5]. However, it 
should be noted that a live attenuated vaccine against DENV developed by Sanofi Pasteur 
(Dengvaxia) has been licensed for use in a limited number of countries, including Mexico and 
the Philippines, although the efficacy of the DENV vaccine in endemic countries is still under 
investigation [6].
2. Brief overview of DENV replication
DENV infection begins with its entry into a permissive cell via receptor‐mediated endocytosis 
(Figure 1). So far, various types of human cells, such as macrophages, lymphocytes, hepa‐
tocytes, and endothelial cells, are reportedly susceptible to DENV infection. Among them, 
monocyte lineage cells (i.e., dendritic cells [DCs] and macrophages) are thought to be the 
primary targets of DENV in humans. As the entry receptors of DENV, several cellular pro‐
teins, including C‐type lectin receptors (e.g., DC‐SIGN/CD209, mannose receptor/CD206) and 
phosphatidylserine receptors (e.g., TIM, TAM), have been demonstrated [7].
Upon entry into the cell, a membrane fusion between DENV envelope (E) glycoprotein and 
endosomal vesicle occurs, leading to the release of viral RNA into the cytoplasm. The DENV 
genome is a single‐stranded positive‐sense RNA and is approximately 10‐kb long. The viral 
RNA contains a single long open reading frame (ORF) flanked by highly structured 5′ and 
3′ untranslated regions (UTRs), with a type 1 cap (m7GpppAmp) at the 5′ terminus and no 
poly(A) tract at the 3’ terminus [8]. The single ORF is translated to a large polyprotein, which is 
subsequently cleaved co‐ and post‐translationally into three structural (capsid [C], pre‐mem‐
brane [prM], and E) and seven non‐structural (NS) proteins (NS1, NS2A, NS2B, NS3, NS4A, 
NS4B, and NS5) by viral (NS3) and host proteases (Figure 1A). Of the NS proteins, NS5, the 
largest viral protein, functions as an RNA‐dependent RNA polymerase (RdRp), which syn‐
thesizes a complementary minus‐strand RNA template and, in turn, produces many  copies of 
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positive‐strand viral genomic RNA. Viral RNA replication takes place in the so‐called repli‐
cation complexes (RCs) composed of viral RNA and proteins as well as hypothetical cellular 
proteins, which are formed on the endoplasmic reticulum (ER) membrane. This membrane 
structure, rearranged by DENV infection, is also the place of viral RNA translation, protein 
processing, and progeny virion assembly [9]. The immature particles then bud into the ER 
lumen and are transported through the secretion pathway of the trans‐Golgi network, in 
which progeny virions undergo a maturation process via a conformational change of prM 
and E proteins on the virion surface. Finally, mature, infectious virions egress from infected 
cells by exocytosis (Figure 1B) [5, 8].
3. Cellular factors involved in DENV replication: interaction with viral 
RNA untranslated regions
As seen in other RNA and DNA viruses, flaviviruses, including DENV, have been shown 
to utilize biological processes of the host to replicate efficiently in infected cells through the 
interaction between viral and cellular proteins. Although the biological relevance of many 
of the host interactors in in vivo replication and the pathogenicity of DENV remain unclear, 
Figure 1. The genome structure and replication cycle of DENV.
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those virus‐host interactions could serve as attractive targets of antiviral drugs [2]. In addition 
to the entry receptors, intracellular factors implicated in the replication cycle of DENV have 
been comprehensively reviewed elsewhere [2, 8, 10, 11]. Meanwhile, it is becoming apparent 
that various cellular cofactors are recruited into the 5′ and 3′ UTRs of DENV RNA, which 
results in enhanced virus replication [12].
The DENV 5′ and 3′ UTRs are approximately 100 and 350–700 nucleotides long, respectively 
(Figure 1A). The primary sequences located within or adjacent to the UTRs have been shown 
to be essential for virus replication [8]. For instance, complementary sequences, termed 
CS (cyclization sequence) elements, found in the ORF of capsid and the 3′ UTR and UAR 
(upstream of the AUG region) elements, found in the 5′ and 3′ UTRs, are reported to physi‐
cally anneal to mediate DENV genome cyclization. This cyclization is likely to recruit the 
DENV RdRp at the 5′ end of the viral genome and then likely to facilitate viral RNA amplifica‐
tion [13]. Additionally, DENV UTRs form stable secondary and tertiary structures, and these 
structural integrities are thought to be important for the regulation of viral RNA synthesis 
and translation process. Therefore, albeit the sequences are diverse, UTR secondary structures 
are highly conserved among flaviviruses [8]. Furthermore, these regions have been demon‐
strated to contain several cellular proteins [12].
An early study that employed an in vitro‐formed nucleoprotein complex of synthesized 
DENV 3′ UTR and mosquito cell extracts identified some RNA‐binding proteins—the La 
autoantigen, translation elongation factor‐1α (EF‐1α), and polypyrimidine tract‐binding pro‐
tein (PTB)—as the DENV UTR‐associated cellular factors in cells [14]. Subsequent studies 
have also revealed that human La protein binds not only with the DENV 3′ UTR but also with 
the 5′ UTR [15, 16]. Interestingly, interactions of La protein with viral proteins NS3 and NS5 
were shown, suggesting that the La protein is somehow involved in the function of RC in 
infected cells [15]. The La autoantigen is reported to associate with RNA polymerase III tran‐
scription; interestingly, this RNA‐binding protein has also been shown to stimulate the trans‐
lation of viral and cellular mRNAs by binding with their UTRs [17]. As with mosquito EF‐1α, 
its human homologue (i.e., EF1A) has been reported to specifically recognize the conserved 
3′‐terminal stem‐loop (SL) in the 3′ UTR of West Nile virus (WNV) RNA [18]. Given the colo‐
calization of EF‐1α with the DENV RC in the infected cell [19], it can be suggested that this 
cellular protein also plays an important role in the function of flaviviral RNA. However, the 
precise step of flaviviral replication in which EF‐1α is involved remains to be elucidated [19].
PTB is a ubiquitous RNA‐binding protein known to be involved in splicing, polyadenyl‐
ation, stability, and translation of cellular mRNA [20]. With regard to its role in virus infec‐
tion, PTB has been shown to bind to the UTRs of picornaviruses [21, 22] and the hepatitis C 
virus (HCV) [23]; it functions as an internal ribosome entry site, (IRES)‐trans‐acting factor, 
to activate viral translation [24, 25]. On the other hand, several studies have raised ques‐
tions about the involvement of PTB in the translation process of those RNA viruses [26–28]. 
Interestingly, both La and PTB were implicated in HCV replication [29]. In the case of DENV 
infection, PTB is reportedly required for efficient replication. Furthermore, PTB interacted 
with a DENV protein, NS4, as well as viral RNA, suggesting that PTB associates with DENV 
RCs [30]. Although it remains unclear whether PTB regulates DENV RNA simplification or 
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the translation process (or another step of virus infection), PTB may function as a molecular 
chaperone to stabilize the structured viral RNA [30, 31]. In addition to the host factors men‐
tioned above, recent studies using tobramycin RNA aptamer affinity chromatography identi‐
fied DDX6 (DEAD‐box RNA helicase) and ERI3 (putative 3′–5′ RNA exonuclease) as DENV 
UTR‐binding cellular proteins that promote DENV replication [32, 33].
The genome of flaviviruses, including DENV, encodes enzymes required for viral RNA syn‐
thesis (i.e., RdRp and helicase) and viral protein processing (i.e., protease); however, the viral 
protein translation process must rely fully on the translational machinery of the host [34], 
except for the methyltransferase activity conferred by NS5, which adds a type 1 7‐methyl‐
guanosine cap to the 5′ terminus of viral RNA. It is, therefore, not surprising that cellular 
factors are associated with DENV RNA during viral translation [8, 35]. At the initiation step 
of eukaryotic mRNA translation, a 5′ cap structure is first recognized by a eukaryotic initia‐
tion factor, eIF4E, which, in turn, leads to the recruitment of eIF4G. eIF4G serves as a scaffold 
protein that binds the DEAD‐box RNA helicase eIF4A and also the poly(A)‐binding protein 
(PABP), resulting in the circularization of mRNA [8]. This complex formation induces the 
association of the 43S ribosomal subunit through the binding of the eIF3 complex. Finally, 
the 60S ribosomal subunit joins the initiation complex that enables the elongation process of 
translation [8]. In the case of DENV, its genomic RNA is 5′ capped but lacks 3′‐end poly(A) 
sequences [8]. Nevertheless, PABP is shown to interact with DENV 3′ UTR in vitro by recog‐
nizing the A‐rich regions upstream of 3′ SL in the 3′ UTR [36]. Indeed, a study using chimeras 
reported that mRNA based on a cellular (globin) gene and DENV RNA revealed that DENV 3′ 
UTR exhibits functions similar to those of polyadenylated non‐viral UTRs in enhancing trans‐
lation rather than RNA stabilization [37]. Thus, it is plausible that as with cellular mRNA, 
translated DENV RNA also forms a closed‐loop structure via association with host translation 
factors [38]. In addition, it is demonstrated that DENV RNA may be able to produce proteins 
by a 5′ cap‐independent translation mechanism in certain cellular situations in which the 
eIF4E is starved and, thereby, canonical host translation is inhibited [39].
4. Experimental procedures for identifying the cellular factors
In the following sections, we summarize several general approaches to search for the cellular 
factors involved in virus infections.
4.1. Conventional methods using living cells
4.1.1. Gene expression analysis and proteomic analysis
Studies using a microarray system, quantitative RT‐PCR analysis, and GeneChip analysis 
have revealed that the expression levels of many mRNAs in host cells are dramatically altered 
upon DENV infection [40–42]. It is highly possible that some of these DENV‐responsible 
genes and their products function as crucial positive or negative regulators of DENV rep‐
lication in cells. Indeed, tumour necrosis factor–related apoptosis‐inducing ligand (TRAIL), 
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whose mRNA expression level significantly increased with DENV infection, was found to be 
a negative regulator of DENV replication [42]. In addition to the analysis of the gene expres‐
sion profile, the global host protein expression profile upon DENV infection was also investi‐
gated by comprehensive proteomic analysis. Conventionally, the total host proteins extracted 
from infected cells and control cells were separated by two‐dimensional PAGE (2‐D PAGE), 
and the proteins whose expression levels were altered by the viral infection were picked up, 
and their amino acid sequences were determined with mass spectrometry (MS) analysis. 
Previous studies have identified many host factors that respond to DENV infection [43, 44]. 
More recently, a proteomic analysis based on stable isotope labelling by amino acids in cell 
culture (SILAC), which overcame the limitations of sensitivity and resolution of 2‐D PAGE, 
was developed and applied to DENV research [45, 46]. The technologies of high‐throughput 
gene expression analysis and proteomic analysis are thought to be powerful tools for under‐
standing the global cellular expression profile of host cells upon DENV infection, both at the 
gene and at the protein levels. From the results of these assays alone, however, it is difficult to 
distinguish whether DENV‐responsible host factors that are identified are indeed involved in 
the regulation of viral replication. To understand the roles and functions of these hit factors 
requires further functional analysis.
4.1.2. RNAi screening
RNA interference (RNAi) is a well‐known approach for identifying novel host factors in 
virus‐infected cells. When the knockdown of a host gene by RNAi alters the efficiency of viral 
replication, it is highly possible that this gene works as a host factor of the virus. Currently, 
commercial siRNA pools that cover most human genes are available, and many genome‐wide 
comprehensive screenings for many kinds of viruses have been performed thus far [47–49]. 
In studies of flaviviruses, hundreds of host factor proteins involved with the early steps of 
WNV infection have been identified by silencing more than 20,000 human genes from a small 
interfering RNA (siRNA) pool [50]. An additional bioinformatic study, followed by the siRNA 
screening, revealed that many of these hits were involved in the ubiquitin‐proteasome path‐
way and the ER‐associated degradation (ERAD) pathway, both of which are essential for 
many steps of viral replication. In addition to host factors in human cells, one study aimed 
to identify host factors from insect cells, another host of DENV [51]. In that study of DENV‐
adapted cells from Drosophila melanogaster and an siRNA pool targeting more than 20,000 
genes of Drosophila, the proteins that accelerate or inhibit the replication of DENV in Drosophila 
cells were identified [51]. Then human analogues of hit genes in Drosophila cells were subse‐
quently silenced in DENV‐infected human cultured cells, and 42 of these were found to be 
common host factors in human and Drosophila cells [51]. It is noteworthy that RNAi screening 
can identify host factors that can affect viral replication either by direct interaction with viral 
components or by indirect interaction, such as the regulation of the IFN pathway.
4.1.3. Yeast two‐hybrid analysis
For researchers attempting to identify host factors that directly interact with viral proteins, 
yeast two‐hybrid (Y2H) analysis is a common and effective way; numerous host factors of 
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many viruses, including DENV, have been identified using this system [52–58]. Taking advan‐
tage of good throughput, several large screenings were performed to build DENV host inter‐
actomes using human cDNA libraries. One study reported that a Y2H analysis using either 
partial or full‐length DNA fragments encoding each DENV protein and the human liver 
cDNA library identified 105 viral‐host interactions; further knockdown experiments using 
siRNAs revealed that six proteins were essential for the efficient viral replication of DENV 
[59]. Another study also carried out a Y2H assay using NS3 and NS5 proteins from DENV and 
other flaviviruses as bait, and 108 human proteins were identified as interacting with NS3 or 
NS5 or both [60]. In addition, Y2H assays were performed to identify DENV proteins inter‐
acting with host factors from human and mosquito cDNA libraries. They identified several 
common host factors conserved in both humans and mosquitos [61]. These studies identified 
many host proteins that interact with DENV proteins; however, few of the hits overlap in 
independent studies. Although this might be caused mainly by the fact that the assay in each 
study was performed in different conditions and with different cDNA libraries, it is also pos‐
sible that each study includes many false positives and false negatives.
4.2. Wheat germ–based protein array system
4.2.1. Overview of the protein array technology
As described above, the living cell‐based methods are powerful tools for identifying viral‐host 
interactions since the assays could be carried out under physiological conditions, at least par‐
tially. However, these methods have several disadvantages. First, proteins whose expression 
levels are quite low or that show cytotoxicity are hard to analyse. Second, immunoprecipitation 
assays are commonly used to detect the interaction between a protein and a protein; however, 
the number of interactions that can be detected at one time is limited. Therefore, it is highly pos‐
sible that many researchers have potentially overlooked important but difficult‐to‐detect inter‐
actions in their first screenings using living cells. To solve these problems, we recently developed 
a novel biochemical screening method based on a wheat germ cell–free protein synthesis system 
(wheat cell‐free system) and high‐throughput binding assay. The wheat cell‐free system enables 
the synthesis of various kinds of eukaryotic proteins in a 96‐well format [62]. So far, proteins 
having several transmembrane domains, relatively large molecular weights, and cytotoxic activ‐
ity were successfully synthesized by this system [63, 64]. This robust protein synthesis system 
allows us to establish a “protein array”, from which tens to thousands of recombinant proteins 
sorted by their functions were arrayed into each well of a 96‐well plate [65]. The protein arrays 
currently available in our research group are shown in Table 1 [65–70]. Based on these protein 
arrays, we have established a high‐throughput binding assay for identifying proteins directly 
bound to target proteins from the array. To perform hundreds to tens of thousands of binding 
reactions, a luminescent‐based binding assay, called AlphaScreen, was employed [65, 66, 71]. 
This assay is able to use crude translation products of wheat cell‐free synthesis to detect binding 
reactions by mixing these crude proteins in a 384‐well plate, followed by adding two beads and 
the antibody for detection. Because of its flexibility, AlphaScreen can be used not only as a bind‐
ing assay but also as a protein cleavage assay for a viral protease. The principle of the assays is 
shown in Figure 2.
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4.2.2. Practical applications for viral research
We and other research groups have done several assays using this technology to identify host 
proteins that interacted with viral proteins. In researching the HCV (a virus related to DENV), 
several protein kinases were found to bind directly with the HCV non‐structural protein 
NS5A using the protein kinase array; by phosphorylating NS5A through additional functional 
analysis using a cultured cell system, one protein kinase, Casein kinase I‐α, was found to regu‐
late viral replication [66]. The protein kinase array was used to identify other host factors that 
Protein array Origin Number of proteins References
Protein kinase Human and mouse 400 Masaki et al. [66], Miyakawa et al. 
[67], Kudoh et al. [68]
E3 ligase Human and mouse 250 Takahashi et al. [65], Tan et al. [69]
Deubiquitinating enzyme Human 85 Unpublished
Single transmembrane protein Human and mouse 730 Unpublished
Auto‐antigen protein Human and mouse 2100 Matsuoka et al. [70]
Table 1. Wheat cell–free‐based protein arrays currently available in our research group.
Figure 2. A schematic diagram of binding assay and protease assay based on AlphaScreen technology.
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functionally interacted with human immunodeficiency virus (HIV) proteins [67, 68]. In the 
case of the protease assay, one research article demonstrated that a protease from xenotropic 
murine leukaemia virus‐related virus (XMRV) and 24 cellular proteins that were target can‐
didates of the viral protease were synthesized; in vitro cleavage assay revealed several novel 
substrates of XMRV protease [72], indicating the feasibility of using wheat cell–free‐based 
protein array technology and high‐throughput biochemical assay based on AlphaScreen.
4.2.3. Wheat cell–free protein array for DENV research
Thus far, NS3 and NS5 proteins of DENV have been considered difficult to synthesize as full‐
length active recombinant proteins using a conventional protein expression system, such as 
for Escherichia coli. We previously reported that the wheat cell‐free system successfully synthe‐
sized full‐length NS3 and NS5 proteins in a soluble form; some biochemical analyses revealed 
that both recombinant proteins possessed enzymatic activities [63], indicating the usefulness 
of the expression system for the preparation of DENV proteins. In addition to these soluble 
proteins, NS4B, a protein with at least three transmembrane domains, was synthesized with 
the wheat cell‐free system (Figure 3A). Our preliminary study demonstrated that NS4B was 
Figure 3. Identification of E3 ligases targeting DENV NS4B by wheat cell‐free‐based protein array system. (A) Expression 
of biotinylated NS4B with wheat cell‐free system. The total translation products of NS4B (T) and supernatant (S) after 
centrifugation of the total translation product were subjected to SDS‐PAGE, followed by immunoblot analysis using anti‐
biotin antibody. M is the molecular marker. (B) Ubiquitination of NS4B. HEK293T cells overexpressing FLAG‐tagged NS4B 
and HA‐tagged ubiquitin were treated with proteasomal inhibitor MG132, and FLAG‐tagged NS4B was precipitated with 
anti‐FLAG antibody. The NS4B and ubiquitin were detected by immunoblot analysis using anti‐FLAG antibody and anti‐
HA antibody, respectively. (C) AlphaScreen assay to identify the E3s targeting DENV NS3 and NS4B proteins using the E3 
protein array. Biotinylated NS3 and NS4B were used as bait, and biotinylated DHFR was used as negative control of NS 
proteins. The relative luminescent signal was calculated as follows: the value from E3 and NS4B/value from E3 and DHFR.
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highly ubiquitinated when NS4B was overexpressed in HEK293T cells (Figure 3B), suggest‐
ing that the amount of NS4B expressed was regulated in host cells in a ubiquitin/protea‐
some‐dependent manner. When a protein is ubiquitinated and, subsequently, degraded by 
the 26S proteasome, E3 is a determinant of the ubiquitination, as E3 specifically binds to the 
target protein and transfers activated ubiquitin from the ubiquitin conjugation enzyme, E2 
[73]. Therefore, we screened NS4B‐binding E3s from the E3 protein array using AlphaScreen, 
as we recently reported [65]. NS3 was used as control to determine the NS4B‐specific E3s. As 
shown in Figure 3C, many E3s were found to bind with recombinant NS4B. Currently, addi‐
tional functional analysis, such as in vitro ubiquitination assay and protein degradation assay 
in cells, is ongoing.
5. Restriction of DENV infection by cellular inhibitors
As previously mentioned, DENV hijacks the host's biological process for its efficient replica‐
tion. Meanwhile, it has become apparent that DENV infection can be limited by cellular fac‐
tors. In this sense, the innate immune response induced by IFN is considered to be the first 
line of defence against DENV [8]
Generally, RNA viruses that infect target cells are sensed by the pattern recognition receptors 
(PRRs), which specifically recognize a component of invading viruses. As for DENV infec‐
tion, the membrane‐bound Toll‐like receptors (TLR3, TLR7, TLR8) and the cytosolic receptors 
(retinoic acid‐inducible gene I [RIG‐I], melanoma differentiation‐associated gene 5 [MDA5]) 
are reported to be the PRRs for viral RNA [74–77]. These recognitions in turn activate adaptor 
molecules of the PRR, leading to the activation of a downstream phosphorylation cascade and 
the subsequent production of IFN and pro‐inflammatory cytokines (Figure 4) [78]. Among 
the IFNs produced, type I IFNs, including IFNα, IFN‐β, and IFN‐ω, play an important role in 
antiviral immunity [79]. The type I IFN then binds to its receptors (IFNAR) on neighbouring 
cells and signals to induce the phosphorylation of signal transducers and the activators of 
transcriptions 1 and 2 (STAT1 and 2) in cytoplasm. This phosphorylation of STAT1/2 triggers 
the formation of IFN‐stimulated gene factor 3 (ISGF3) with IFN‐regulatory factor 9 (IRF9). 
Finally, the ISGF3 complex translocates to the nucleus and acts as a transcription activator 
for the expression of a number of genes by binding to the IFN‐stimulated response elements 
(ISREs) on chromosomes (Figure 4) [80].
As seen above, IFN is considered to be an inducer of the antiviral state, and it has been well 
demonstrated that actual antiviral effector molecules in the IFN response are a subset of the 
genes upregulated by IFN, which are called IFN‐stimulated genes (ISGs). Thus far, hundreds 
of genes have been classified as ISGs, and many of them are reported to have inhibitory effects 
on divergent families of viruses, including flaviviruses [80–83]. Importantly, several ISGs 
have also been shown to restrict DENV infection, and their suppressive effects are likely to 
be exerted at the multiple steps of virus replication, including virus entry (IFITMs [84, 85], 
ADAP2 [86]), viral RNA/protein synthesis (ISG20 [87], viperin [88, 89]), and infectious virion 
production (tetherin [90], ISG15 [91, 92]). In addition, a comprehensive study using an over‐
expression of a cDNA library derived from known ISGs demonstrates the involvement of 
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many more ISGs in the restriction of DENV [93]. However, the precise mechanisms of these 
ISG‐mediated anti‐DENV activities remain unclear, and we will have to wait for future stud‐
ies for detailed analysis.
6. Identification of RyDEN/C19orf66 as novel anti‐DENV ISG
It has been well demonstrated that a gain‐of‐function (i.e., overexpression) screen of cDNA 
is a powerful approach to identifying antiviral ISGs [82, 83, 93, 94]. In a recent study, we 
employed the gain‐of‐function strategy using a pool of cDNA library derived from type 1 
IFN‐treated cells to search for ISGs suppressing DENV replication in human cells [95]. In this 
approach, a human cervical carcinoma cell line, HeLa, was treated with type I IFN (a mixture 
of human IFN‐α and ‐ω) for 24 hours at a concentration that had been reported to inhibit 
DENV infection in vitro [96], and mRNA from the IFN‐treated HeLa cells was converted into a 
library of cDNA and transferred to a HIV‐based lentiviral vector. Then, a human hepatoma cell 
Figure 4. Intracellular recognition of RNA viruses and IFN responses (left). PRRs‐sensing virus‐specific nucleic acid 
structures (ssRNA and dsRNA) activate signalling cascades via phosphorylation of transcription factors (IRF3 and 
IRF7), which leads to the expression of IFN genes together with NF‐κB (right). Binding of IFNs produced from virus‐
infected cells to type I IFN receptor (IFNAR) activates JAK1 and TYK2, which, in turn, phosphorylate STAT1 and STAT2. 
Phosphorylation of STAT1/2 induces the formation of ISGF3 complex with IRF9, and finally, ISGF3 translocated in 
nucleus binds to ISREs to induce ISG expressions. ssRNA, single‐stranded RNA; dsRNA, double‐stranded RNA; MAVS, 
mitochondrial antiviral‐signalling protein; JAK1, Janus kinase 1; and TYK2, tyrosine kinase 2.
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line, Huh7.5, was exposed to the HIV vector carrying the IFN cDNA library. Huh7.5 cells are 
highly susceptible to DENV and, therefore, exhibit massive cell death upon DENV infection. 
Therefore, we expected that if anti‐DENV genes derived from IFN‐treated HeLa cells were 
introduced into DENV‐permissive Huh7.5 cells, those cells should be non‐permissive and 
survive DENV‐induced cell death. As anticipated, even with the DENV challenge, surviving 
cell clones were obtained; subsequent sequencing analysis revealed that approximately half 
of DENV‐resistant clones harboured an ORF of a gene on chromosome 19, C19orf66, in the 
integrated HIV vector genome [95]. Since C19orf66 was a previously uncharacterized gene, we 
named this repressor of yield of DENV (RyDEN).
The ORF of RyDEN (C19orf66) encodes a 291 amino acid protein, and the secondary structure 
prediction suggested that the RyDEN protein contained a nuclear localization signal (NLS) in 
the middle region and a nuclear export signal (NES) in the C‐terminal region. Additionally, a 
characteristic glutamic acid (E)‐rich domain was found in the C‐terminus.
The anti‐DENV activity of RyDEN was confirmed by creating stable cell lines that expressed 
epitope tag‐fused human hepatoma cell lines, and all DENV serotypes (i.e., DENV‐1–4) were 
found to be inhibited by RyDEN expressions. In line with the fact that this gene was first 
identified by the gain‐of‐function approach using an IFN‐derived cDNA library, expressions 
of RyDEN in various human cell lines were upregulated by IFN treatment to a greater or 
lesser extent, indicating that RyDEN is a bona fide anti‐DENV ISG. More importantly, when 
the endogenous expression of RyDEN mRNA was knocked down by RNAi, the suppressive 
activity of type I IFNs against DENV became less effective, suggesting that RyDEN was a 
major contributor of the IFN‐mediated anti‐DENV response [95].
One question to ponder: what is the molecular mechanism by which RyDEN suppresses 
DENV replication? Affinity purification‐mass spectrometry analysis with affinity tag‐fused 
RyDEN found that RyDEN interacted with two other cellular proteins, poly(A)‐binding pro‐
tein cytoplasmic 1 (PABPC1) and La motif‐related protein 1 (LARP1). PABPC1 is a member 
of the PABP family; as described above, this protein bridges the 5′ and 3′ ends of mRNA by 
binding both the eIF4G and the poly(A) tail, which stimulates the initiation of translation [97]. 
LARP1 is also an RNA‐binding protein and one of the LARPS, which shares the signature 
motif with the La autoantigen, called the La motif (LM). Therefore, Larp and La proteins are 
categorized as being in the same family [98]. Intriguingly, LARP1 is shown to interact with 
PABP to stimulate the mRNA translation process [99, 100]. Considering the positive effect 
of PABP on translation [97], the association of PABPC1 and LARP1 with RyDEN suggests 
that RyDEN might interfere with the translation of DENV RNA by inhibiting PABPC1 and 
LARP1 functions. Indeed, this speculation was supported by the following findings: (i) an 
RNAi‐mediated knockdown of PABPC1 and LARP1 significantly reduced the level of DENV 
replication, (ii) PABPC1 interacted with DENV RNA in infected cells, (iii) the expression of 
RyDEN suppressed the expression of the reporter protein from a DENV‐based sub‐genomic 
RNA replicon that lacked structural (C, prM, E) genes, and (iv) the recruitment of RyDEN 
to the DENV RNA 3’ UTR was enhanced by the presence of PABPC1 in vitro [95]. Therefore, 
one could envisage that the anti‐DENV activity of RyDEN, an antiviral ISG, is exerted during 
the translation of viral RNA by associating PABPC1/LARP1 with the 3′ UTR and somehow 
interfering with the function of the translation factors (Figure 5). Or another possibility is that 
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RyDEN may facilitate the degradation of viral RNA, since PABPC1 and LARP1 have been 
reported to be involved in eukaryotic mRNA decay as processing body (P‐body) and stress 
granule (SG) components (Figure 5) [99, 101]. In accordance with this notion, a recent study 
revealed that RyDEN (also referred to as FLJ11286 or IRAV) was colocalized with cytoplasmic 
P‐bodies in IFN‐treated cells [102]. Furthermore, it was noteworthy that RyDEN expression 
limited a diverse range of RNA and DNA viruses [83, 95, 102], indicating that RyDEN is a 
broad‐spectrum antiviral ISG.
7. Concluding remarks
This chapter highlighted the molecular interactions between DENV and host factors, particu‐
larly focused on the cellular regulation of DENV replication. As is well known, IFN response 
is one of the host controls of DENV infection and pathogenesis [96, 103, 104]. Although the 
effector molecules in the IFN response that actually interfere with virus replication remain 
fully clarified, profound efforts have been made to identify the IFN‐inducible cellular factors 
restricting RNA virus replication, including DENV [80]. It should be noted that antagonistic 
Figure 5. Possible mechanisms by which RyDEN restricts the function of DENV RNA. RyDEN, whose expression is 
upregulated by IFN, associates with DENV RNA through interaction with PABPC1 and LARP1 that are required for 
DENV replication. This association may result in (i) translational suppression or (ii) degradation of viral RNA in the 
cytoplasm.
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effects of DENV infection on IFN signalling and production, which are mediated by several 
means using viral factors, are observed [105–107]. However, the characterization of anti‐
DENV ISGs is to illuminate the “heel of Achilles” of DENV, which will provide the underpin‐
nings for the development of antivirals against dengue.
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